GLENN L MD COOPER Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GLENN L MD COOPER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GLENN L MD COOPER. GLENN L MD COOPER is President and CEO in Endo Pharmaceuticals Solutions Inc. ($IDEV) and Director in REPLIGEN CORP ($RGEN).
Latest Insider Trading Transactions of GLENN L MD COOPER
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 28 2019 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Sell | S | 67.53 | 266 | 17,963 | 35,709 | 36 K to 35.7 K (-0.74 %) |
| May 28 2019 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Sell | S | 66.91 | 4,734 | 316,752 | 35,975 | 40.7 K to 36 K (-11.63 %) |
| May 17 2019 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Option Exercise | A | 67.71 | 2,109 | 142,800 | 2,109 | |
| May 17 2019 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Grant | A | 0.00 | 923 | 0 | 40,709 | 39.8 K to 40.7 K (+2.32 %) |
| May 17 2018 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Option Exercise | A | 42.07 | 3,304 | 138,999 | 3,304 | |
| May 17 2018 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Grant | A | 0.00 | 1,486 | 0 | 39,786 | 38.3 K to 39.8 K (+3.88 %) |
| May 22 2017 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Option Exercise | A | 38.76 | 2,434 | 94,342 | 2,434 | |
| May 22 2017 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Grant | A | 0.00 | 1,206 | 0 | 38,300 | 37.1 K to 38.3 K (+3.25 %) |
| May 13 2016 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Option Exercise | A | 26.12 | 3,366 | 87,920 | 3,366 | |
| May 13 2016 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Grant | A | 0.00 | 1,763 | 0 | 37,094 | 35.3 K to 37.1 K (+4.99 %) |
| Nov 12 2015 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Grant | A | 26.56 | 1,000 | 26,564 | 35,331 | 34.3 K to 35.3 K (+2.91 %) |
| May 26 2015 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Option Exercise | A | 41.19 | 1,992 | 82,050 | 1,992 | |
| May 26 2015 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Grant | A | 0.00 | 1,019 | 0 | 34,331 | 33.3 K to 34.3 K (+3.06 %) |
| Mar 11 2005 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 3.70 | 75,000 | 277,500 | 75,000 | |
| Feb 16 2005 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Buy | P | 4.05 | 10,000 | 40,500 | 185,000 | 175 K to 185 K (+5.71 %) |
| Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 5.00 | 60,000 | 300,000 | 60,000 | |
| Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | D | 5.00 | 60,000 | 300,000 | 0 | |
| Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 4.16 | 60,000 | 249,600 | 60,000 | |
| Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | D | 4.16 | 60,000 | 249,600 | 0 | |
| Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 6.19 | 800,000 | 4,952,000 | 800,000 | |
| Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | D | 6.19 | 800,000 | 4,952,000 | 0 | |
| Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 4.16 | 300,000 | 1,248,000 | 300,000 | |
| Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | D | 4.16 | 300,000 | 1,248,000 | 0 | |
| Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 5.00 | 60,000 | 300,000 | 60,000 | |
| Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | D | 5.00 | 60,000 | 300,000 | 0 | |
| Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 4.16 | 60,000 | 249,600 | 60,000 | |
| Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | D | 4.16 | 60,000 | 249,600 | 0 | |
| Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 6.19 | 800,000 | 4,952,000 | 800,000 | |
| Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | D | 6.19 | 800,000 | 4,952,000 | 0 | |
| Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 4.16 | 300,000 | 1,248,000 | 300,000 | |
| Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | D | 4.16 | 300,000 | 1,248,000 | 0 | |
| Mar 12 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 5.92 | 150,000 | 888,000 | 150,000 |
Page: 1